Context Therapeutics Inc (CNTX) — Financial Flexibility Index
Context Therapeutics Inc (CNTX) has a Financial Flexibility Index of -0.88x as of June 2026. Free cash flow of $-7.00 Million (operating CF $-7.02 Million minus capex $18.49K) represents -1% of total liabilities ($7.96 Million). Check CNTX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Context Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Context Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Context Therapeutics Inc.
Annual Financial Flexibility Index for Context Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Context Therapeutics Inc. Explore CNTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.29x | $-26.35 Million | $-26.39 Million | $8.02 Million | ▼ -4776.0% |
| 2024 | 0.07x | $201.00K | $-14.56 Million | $2.86 Million | ▲ +101.4% |
| 2023 | -5.02x | $-21.05 Million | $-21.05 Million | $4.19 Million | ▼ -23.8% |
| 2022 | -4.06x | $-13.01 Million | $-13.55 Million | $3.21 Million | ▼ -43.9% |
| 2021 | -2.82x | $-8.55 Million | $-8.80 Million | $3.03 Million | ▼ -4636.8% |
| 2020 | -0.06x | $-1.03 Million | $-1.03 Million | $17.39 Million | ▲ +49.2% |
| 2019 | -0.12x | $-2.84 Million | $-2.84 Million | $24.23 Million | ▲ +95.1% |
| 2017 | -2.38x | $-22.32 Million | $-22.35 Million | $9.38 Million | ▲ +15.2% |
| 2016 | -2.80x | $-30.54 Million | $-30.57 Million | $10.89 Million | — |